Affymetrix Reaches Deal with Genisphere for RNA Amplification, Labeling Technology | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix today said it is exclusively licensing on a worldwide basis technology from Genisphere for RNA amplification and labeling to address challenging sample types, such as formalin-fixed, paraffin embedded samples, for Affy's GeneChip Arrays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.